Tag Archives: blood clot prevention

NHMRC boss: we are looking into management of competing interests

May 2, 2009 – 7:00 pm

Professor Warwick Anderson, ceo of the NHMRC, has sent in the following comment re the guidelines controversy. (Readers with an interest in these issues may want to check out the details of a workshop being held by the NHMRC in Canberra on June 2):
“Last week, the National Health and Medical Research Council (NHMRC) released for [...]

By Croakey | Posted in Hospitals, Journal articles, conflicts of interest, evidence-based issues | Also tagged , , | Comments (0)

Guidelines should be divorced from industry: Prof Guy Maddern

May 2, 2009 – 6:52 pm

Professor Guy Maddern, professor of surgery at the University of Adelaide, comments on the ongoing controversy over guideline development (see posts below for more background):
“The nature and content of health care needs to be constantly reviewed.   This remains an enormous challenge as the impact of new developments, new understandings of disease and the access to [...]

By Croakey | Posted in Hospitals, conflicts of interest, evidence-based issues, health & medical marketing, surgery | Also tagged , | Comments (1)

Some critical issues for clinical practice guidelines

April 27, 2009 – 10:08 am

Agnes Vitry, Senior Research Fellow, School of Pharmacy and Medical Sciences, University of South Australia, has sent in this detailed, thoughtful response to the recent Croakey survey on the issues surrounding the controversial, commercially-funded Australian and NZ guidelines for blood clot prevention (for more background, see previous Croakey posts).
Vitry’s comments are well worth a read:
1. [...]

By Croakey | Posted in Hospitals, Journal articles, conflicts of interest, evidence-based issues, health & medical marketing, pharmacy, prevention, surgery | Also tagged , , | Comments (0)

The guidelines controversy: what do the experts think?

April 23, 2009 – 11:18 am

Following the recent controversy about Australian and NZ guidelines for preventing blood clots, Croakey asked some relevant parties for their views on:
• whether  health departments, hospitals,  safety and quality groups be reviewing their support for these particular  guidelines in response to the concerns raised in the MJA and elsewhere?
• whether such agencies also review their [...]

By Croakey | Posted in Hospitals, Journal articles, Media-related issues, adverse events, conflicts of interest, evidence-based issues, health & medical marketing, prevention, quality and safety of health care, surgery, trauma | Also tagged , , , | Comments (1)